US Patent 11883386 Prolyl hydroxylase inhibitors and methods of use
Patent 11883386 was granted and assigned to Akebia Therapeutics on January, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11883386 Prolyl hydroxylase inhibitors and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
